Dr Alan M Lessner, MD | |
6801 Nw 9th Blvd, Suite 2, Gainesville, FL 32605-4269 | |
(352) 331-1371 | |
(352) 331-1913 |
Full Name | Dr Alan M Lessner |
---|---|
Gender | Male |
Speciality | Plastic And Reconstructive Surgery |
Experience | 40 Years |
Location | 6801 Nw 9th Blvd, Gainesville, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528013513 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207WX0200X | Ophthalmology - Ophthalmic Plastic And Reconstructive Surgery | ME0049380 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
North Florida Regional Medical Center | Gainesville, FL | Hospital |
Mailing Address | Practice Location Address |
---|---|
Dr Alan M Lessner, MD 6801 Nw 9th Blvd, Suite 2, Gainesville, FL 32605 Ph: (352) 331-1371 | Dr Alan M Lessner, MD 6801 Nw 9th Blvd, Suite 2, Gainesville, FL 32605-4269 Ph: (352) 331-1371 |
News Archive
Scientists across the globe are rushing to find inhibitors of SARS-CoV-2, the new coronavirus behind the COVID-19 pandemic.
As President Obama on Monday met with health care industry groups regarding their pledge to reduce $2 trillion in expected health care spending increases over the next 10 years, many health care advocates expressed skepticism about the promise, the Hartford Courant reports (Levick, Hartford Courant, 5/12).
To add to existing CRISPR-based nucleic acid detection protocols, a team of researchers recently established a new SARS-CoV-2 detection protocol based on their previously reported platform - CDetection (Cas12b-mediated DNA detection). They combined nucleic-acid amplification methods and sample treatment protocols with CDetection and established an integrated nucleic acid detection platform called CRISPR-assisted detection or CASdetec. CASdetec has a detection limit of 1×104 copies/mL for SARS-CoV-2 pseudovirus, without any observed cross-reactivity.
Apitope, the drug discovery and development company focused on disease-modifying treatments for patients with autoimmune and allergic diseases, announced today that it has started preclinical development of its novel peptide therapy ATX-GD-459 for the treatment of Graves' disease.
› Verified 1 days ago
Dr. Casey Justin Beal, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1600 Sw Archer Rd, Box 100284, Gainesville, FL 32610 Phone: 352-273-8778 | |
Ramin Daneshvar, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6201 W Newberry Rd, Gainesville, FL 32605 Phone: 352-265-2020 Fax: 352-273-8787 | |
Dr. Gregory Snodgrass, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4313 Nw 8th Ave, Gainesville, FL 32605 Phone: 352-373-4300 Fax: 352-372-1641 | |
Renata Martins De Barros Mancano, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 6201 W Newberry Rd, Gainesville, FL 32605 Phone: 352-265-2020 | |
Dr. Firoozeh Raygan, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 6201 W Newberry Rd, Gainesville, FL 32605 Phone: 352-265-2020 | |
Dr. Sonal S Tuli, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6201 W Newberry Rd, Gainesville, FL 32605 Phone: 352-265-7080 Fax: 352-265-7081 | |
Dr. Nausheen Khuddus, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7120 Nw 11th Pl, Gainesville, FL 32605 Phone: 352-261-0089 Fax: 386-755-1128 |